With age, the growth plate undergoes senescent changes that cause linear bone growth to slow and finally cease. Based on previous indirect evidence, we hypothesized that this senescent decline occurs because growth plate stem-like cells, located in the resting zone, have a finite proliferative capacity that is gradually depleted. Consistent with this hypothesis, we found that the proliferation rate in rabbit resting zone chondrocytes (assessed by continuous 5-bromo-2 -deoxy-uridine labeling) decreases with age, as does the number of resting zone chondrocytes per area of growth plate.
Introduction
In humans, the rate of longitudinal bone growth, and hence the rate of overall linear growth, decreases with age. The prenatal linear growth rate exceeds 100 cm/year. However, by the time of birth, the growth rate has fallen to about 50 cm/year, and at the age of 10 years the growth rate is about 5 cm/year. This decline is briefly interrupted by a pubertal growth spurt, after which the deceleration resumes and the growth rate approaches zero (Tanner & Davies 1985) . In other mammals, a similar dramatic decline in growth rate occurs, but without a superimposed pubertal growth spurt. Kember and Walker (1971) showed that this senescent decline in growth rate is due, in large part, to a decrease in the proliferation rate of growth plate chondrocytes. These functional senescent changes are accompanied by structural senescent changes. There is a gradual decline in the overall growth plate height, proliferative zone height, hypertrophic zone height, size of hypertrophic chondrocytes, and column density (Kember & Walker 1971 , Kember 1973 , Masoud et al. 1986a , Masoud et al. 1986b , Walker & Kember 1972a , Walker & Kember 1972b , Hunziker & Schenk 1989 , Farquharson & Loveridge 1990 . The growth plate undergoes ossification as the final step in the senescence program .
Growth plate senescence appears to be caused by a mechanism intrinsic to the growth plate (Nilsson & Baron 2004) . Previous studies suggest that information about the prior growth history is retained within the growth plate and influences subsequent growth plate structure and function . The cell most likely to carry this information is the resting zone chondrocyte because it is the only cell involved in the growth process that remains in the growth plate over long periods of time.
Any information carried by the proliferative/hypertrophic chondrocytes would presumably be lost when these cells reach the metaphyseal border of the growth plate, undergo apoptosis, and are replaced by bone (Farnum & Wilsman 1987) .
We have recently shown evidence that the resting zone chondrocytes serve as a pool of stem-like cells that generate columnar clones of proliferative zone chondrocytes . We have also found evidence suggesting that growth plate senescence is not a function of time per se but rather of the cumulative number of divisions that the chondrocytes have undergone . Taken together, these previous findings suggest the following model: 1) stem-like cells in the resting zone have a finite proliferative capacity which is gradually exhausted; 2) as this proliferative capacity is exhausted, the proliferation rate of the proliferative zone chondrocytes (which are derived from the stem-like cells) decreases, causing longitudinal bone growth to slow with age and eventually cease.
This depletion of the stem-like cells in the resting zone could be qualitative and/or quantitative; with age there could be a decrease in the proliferative capacity per stem-like cell and/or a decrease in the number of stemlike cells. However, little is known about these chondrocytes. Even their proliferation rate has not been previously measured, perhaps because it is too slow to be assessed by pulse labeling approaches.
Based on our model, we hypothesized that the proliferation rate of resting zone chondrocytes decreases with age, reflecting their diminishing proliferative capacity. We have previously shown evidence that glucocorticoid slows growth plate senescence . Therefore, we further hypothesized that glucocorticoid acts by slowing resting zone chondrocyte proliferation, thus conserving their proliferative capacity and hence slowing senescence. In contrast, estrogen accelerates growth plate senescence , raising the possibility that estrogen might stimulate resting zone chondrocyte proliferation and thus accelerate depletion of their proliferative capacity.
Materials and Methods

Animal experiments
New Zealand White (NZW) male rabbits (Covance Research Products, Denver, PA, USA) were housed and cared for in accordance with the Guide for the Care and To study the effect of age on resting zone proliferation in vivo, animals were studied at the end of gestation, and at postnatal week 5, 9, and 17. The first time point represents the initial period of very rapid longitudinal bone growth. For simplicity, we refer to this time point as 0 weeks of age. The remaining time points represent the subsequent period of progressively decreasing growth (Masoud et al. 1986b . To avoid the confounding effects of gonadal steroids, rabbits studied at 9 and 17 weeks of age were previously castrated at 6 weeks of age. Five-week-old animals remained intact because they are sexually immature. Because resting zone cells replicate slowly, we made the measurement of proliferation rate by prolonged, continuous labeling of newly synthesized DNA using 5-bromo-2 -deoxy-uridine (BrdU). Pregnant females (gestational age 22 days, n=2) and 5-, 9-, and 17-week-old New Zealand White male rabbits (n=6-8 per group) received a subcutaneous osmotic minipump (2 ML-1; Alza Corp, Palo Alto, CA, USA) delivering BrdU (Sigma-Aldrich Corp.) suspended in physiological saline at a rate of 200 µg BrdU/kg/h. After the one-week infusion period, animals were killed by pentobarbital overdose. The pregnant females were killed at 29 days gestation, and a total of twelve fetuses were studied. Growth plate collections were made from the distal femur (DF), proximal tibia (PT), and distal tibia (DT). Growth plates were fixed in 10% phosphate-buffered formalin for 24 h, decalcified in 0·5 M EDTA, placed in 70% ethanol for storage, and embedded in paraffin, after which longitudinal 5 µm sections were obtained from the center of the bone.
To study the effect of dexamethasone and estrogen on resting zone proliferation, animals received either estradiol cypionate (Pharmacia & Upjohn Company, Kalamazoo, MI, USA), 70 µg/kg i.m. weekly, dexamethasone (Phoenix Pharmaceutical, St Joseph, MO, USA), 0·5 mg/kg s.c. daily or vehicle (cottonseed oil im weekly as vehicle for estradiol cypionate and normal saline s.c. daily as vehicle for dexamethasone) for two weeks (n=6-7 per treatment group). This dose of estradiol cypionate produces nearphysiological adult levels . This dose of dexamethasone is supraphysiological and has previously been shown to inhibit growth ) and cause osteoporosis . Animals were weaned at 3 weeks of age. Treatment was begun at 4 weeks of age and lasted 2 weeks. After the first week of treatment, all animals underwent minipump implantation to deliver BrdU (200 µg BrdU/kg per hour). After a total of 2 weeks treatment, animals were killed by pentobarbital overdose. Blood was drawn prior to sacrifice for measurement of estradiol and insulin-like growth factor I (IGF-I). Growth plates were isolated as described previously.
Immunohistochemistry
BrdU-labeled cells in growth plates were visualized by immunohistochemical staining using BrdU in situ detection kit II (BD Biosciences Pharmingen, San Diego, CA, USA). BrdU staining was performed as per the manufacturer's protocol, except that the antigen-retrieval time was extended to 15 min. Subsequently, the antigen-retrieval solution was allowed to cool down to room temperature for 25 min, and the incubation with anti-BrdU antibody was done overnight at 4 C. Sections were counterstained lightly with hematoxylin. As a negative control, sections of bone from animals not infused with BrdU were subjected to the same immunohistochemical procedure; no staining was observed.
Cell kinetics
In fetal animals, the resting zone can be subdivided into two regions, the reserve cartilage and the epiphyseal cartilage. The reserve cartilage lies closest to the proliferative zone and contains flattened chondrocytes. These chondrocytes are often grouped in pairs aligned parallel to the long axis of the bone. The epiphyseal cartilage lies further from the proliferative zone and thus closer to the bony epiphysis than the reserve cartilage. The epiphyseal cartilage contains round or elliptical chondrocytes, mostly scattered individually in the cartilage matrix . In older animals, both reserve chondrocytes and epiphyseal chondrocytes are far less numerous and they are more intermixed, without a distinct boundary (Fig. 1) . We measured the BrdU-labeling index and numbers of cells in both subpopulations. Because the distinction is subjective, we also analyzed these measurements for the overall resting zone, including both cell types.
A single, blinded observer assessed cell proliferation by light microscopy. The central two-thirds of the growth plate was used for analysis; the lateral portions of the growth plate adjacent to the perichondrium were excluded. The BrdU-labeling index was defined as the number of BrdU-labeled cells divided by the total number of labeled and unlabeled cells (with visible nuclei, counted using phase contrast). The calculation of the labeling index in each growth plate was based on at least 300 cells. We also assessed the number of resting zone cells per millimeter growth plate, measured perpendicular to the Figure 3 Effect of age on the proliferation rate of chondrocytes in the overall resting zone (A), and in the epiphyseal region (B), and the reserve region (C) of the resting zone. 0-(late fetal), 5-, 9-, and 17-week-old rabbits (n=6-12 per group) were infused with BrdU for one week. BrdU labeling was assessed immunohistochemically in distal femur d, proximal tibia •, and distal tibia . The BrdU-labeling index represents the number of BrdU-labeled cells divided by the total number of labeled and unlabeled cells. There is an overall effect of age for all three panels. P<0·001, ANOVA; *P c0·001 for pairwise comparison.
long axis of the bone. This value reflects, in three dimensions, the number of resting zone chondrocytes in the growth plate, divided by the circular area of the growth plate.
Assays
Serum IGF-I and estradiol concentrations were measured by radioimmunoassay at Esoterix Inc. (Austin, Texas, USA).
Statistical analysis
Data are presented as mean S.E.M. The effects of age, estrogen, and dexamethasone on resting zone proliferation and on number of cells were evaluated by two-way repeated-measures ANOVA. For the effect of age, the ANOVA was followed by Holm-Sidak tests for pairwise multiple comparison. We chose not to analyze differences among different growth plates because these comparisons would have had less statistical power than the overall comparisons due to smaller sample size and the need to correct for multiple comparisons.
Results
Effects of age
The BrdU-labeling index in the resting zone decreased significantly with age (P<0·001, Fig. 2 and 3 ). For example, in the distal femur the labeling index decreased from 95·6 0·8% at 0 weeks of age to 9·2 1·2% at 5 weeks, 9·2 1·1% at 9 weeks, and 7·6 1·5% at 17 weeks of age. We also subdivided the resting zone into the epiphyseal region and the reserve resting zone. The BrdU-labeling index decreased with age in both regions (P<0·001, Fig. 3B and C) , although, in the epiphyseal region, a significant decrease was only observed during the 0 -5 week interval.
The 1-week continuous infusion of BrdU labeled essentially all proliferative chondrocytes, thus confirming that the proliferation rate in proliferative zone chondrocytes is more rapid than in resting zone chondrocytes. The hypertrophic chondrocytes were also all labeled, presumably because proliferative chondrocytes were labeled and then underwent terminal differentiation to become hypertrophic chondrocytes. We could confirm that this widespread labeling in the proliferative zone and the hypertrophic zone was not artifactual because it was not seen in control animals that did not receive BrdU, Figure 4 Effect of age on the number of chondrocytes in the overall resting zone (A), and in the epiphyseal region (B), and the reserve region (C) of the resting zone. The number of cells per mm of growth plate (measured perpendicular to the long axis of the bone) was assessed in the distal femur d, proximal tibia •, and distal tibia of 0-(late fetal), 5-, 9-, and 17-week-old rabbits (n=6-12 per group). In the fetal rabbit, the number of cells is shown only as a lower limit because, at this age, there is no secondary ossification center to form an upper margin of the resting zone and therefore the resting zone extended beyond the counting area. There is an overall effect of age for all three panels. P<0·001, ANOVA; * P<0·001 for pairwise comparison.
and because a single injection of BrdU produced more selective labeling of proliferative zone chondrocytes and no labeling of hypertrophic zone chondrocytes (data not shown).
The number of resting zone chondrocytes per mm of growth plate also decreased with age in the overall resting zone (P<0·001, Fig. 4A ), in the epiphyseal resting zone (P<0·001, Fig. 4B) , and in the reserve resting zone (P<0·001, Fig. 4C ).
Effects of dexamethasone and estradiol
To gain insight into the effect of hormones on the resting zone, 4-week-old rabbits were treated with dexamethasone, estradiol, or vehicle for two weeks. BrdU-labeling was performed during the second week of the treatment.
The BrdU-labeling index in the resting zone decreased with dexamethasone treatment (P<0·001, Fig. 5A ). This decrease was seen in both the epiphyseal (P<0·001, Fig. 5B ) and the reserve resting zone (P<0·001, Fig. 5C ). The number of resting zone chondrocytes was greater with dexamethasone treatment (P=0·016, Fig. 6A ). This effect was detected in the reserve resting zone (P<0·001, Fig. 6C ), but not in the epiphyseal resting zone (Fig. 6B) . Dexamethasone treatment did not significantly affect serum IGF-I concentration (112 8 ng/mL vs 108 6 ng/mL, dexamethasone vs control, P=NS).
The BrdU-labeling index in the resting zone was decreased by estrogen treatment (P=0·011, Fig. 7A ). This decrease occurred in the epiphyseal resting zone (P=0·008, Fig. 7B ), but the decrease did not reach statistical significance in the reserve resting zone (P=0·06, Fig. 7C ). Estrogen treatment did not significantly affect the number of resting zone chondrocytes (data not shown). Serum estradiol concentration, measured 7 days after the second injection of estradiol cypionate, was 11 2 pg/mL, compared to<5 pg/mL in animals treated with the vehicle. Estrogen treatment did not significantly affect serum IGF-I concentration (88 6 ng/mL vs 108 6 ng/mL, estrogen vs control, P=NS).
Discussion
We found that the proliferation rate of cells in the resting zone, both the epiphyseal and reserve regions, decreased with age. This finding supports our hypothesis that the proliferative capacity of the stem-like cells in the resting zone decreases with age, and thus the stem-like cells become depleted qualitatively. This decrease in Figure 5 Effect of dexamethasone on proliferation of chondrocytes in the overall resting zone (A), and in the epiphyseal region (B), and the reserve region (C) of the resting zone. 4-week-old rabbits were treated with dexamethasone (0·5 mg/kg sc daily) or vehicle (normal saline) for two weeks. BrdU was infused during the second week of the treatment. BrdU-labeling was assessed immunohistochemically in the distal femur (DF), proximal tibia (PT), and distal tibia (DT). P values are for dexamethasone vs vehicle, ANOVA.
proliferative capacity could explain the decreased proliferation in the proliferative zone chondrocytes which are thought to be derived from the stem-like cells , and thus could also explain the decline in growth rate with age.
Although we attribute the decrease in proliferation with age to a decrease in the proliferative capacity, this decreased capacity is not necessarily cell autonomous and irreversible. The decrease in proliferative capacity could be context-dependent, and reversible. Previous studies suggest that the decrease is not due to hormonal or other systemic factors (Nilsson & Baron 2004) , but the decrease could reflect a local change in concentrations of paracrine growth factors.
We also found that the number of resting zone chondrocytes decreased with age in both epiphyseal and reserve resting zone in the rabbit. Thus quantitative depletion of resting zone chondrocytes also occurred with age. This quantitative depletion could explain the reduction in column density that occurs with growth plate senescence , because with age there would be fewer stem-like cells to generate new columns, potentially increasing the spacing of the columns in the proliferative zone. If, with age, the resting zone generates proliferative columnar clones less often, the proliferative zone might be populated with older clones, which might also contribute to the decline in growth rate. Eventually, with age, the resting zone becomes essentially depleted of cells, after which time longitudinal bone growth can presumably only continue until the proliferative capacity of the existing clones of proliferative chondrocytes is exhausted. The decline in number of resting zone chondrocytes could also affect growth rate by a paracrine mechanism. For example, a decrease in the number of resting zone chondrocytes might decrease the overall production of parathyroid hormone-related protein (PTHrP), which could lead to earlier hypertrophy of proliferative zone chondrocytes.
The observed decrease in the number of resting chondrocytes with age presumably results, at least in part, from the observed decrease in proliferation of these cells. However, it is not known whether other factors may also contribute to this decrease in cell number, for example: an increase in the rate of cell death with age, an increase in the number of resting zone chondrocytes exiting to the proliferative zone, or an increase in the number of resting zone chondrocytes that hypertrophy and are then replaced in the secondary ossification center.
Previous studies have shown evidence that glucocorticoid excess slows the rate of growth plate senescence.
Figure 6
Effect of dexamethasone treatment on the number of chondrocytes per millimeter in the overall resting zone (A), and in the epiphyseal region (B), and the reserve region (C) of the resting zone. 4-week-old rabbits were treated with dexamethasone (0·5 mg/kg sc daily) or vehicle (normal saline) for two weeks. The number of cells per mm of growth plate (measured perpendicular to the long axis of the bone) was assessed in the distal femur (DF), proximal tibia (PT), and distal tibia (DT). P values are for dexamethasone vs vehicle, ANOVA.
Consequently, after a period of glucocorticoid-induced growth inhibition, the growth plates appear less senescent than expected for age and therefore grow at a greater than normal rate, causing catch-up growth . To explain the delay in senescence and the ensuing catch-up growth, we hypothesized that glucocorticoid excess decreases the proliferation rate in the resting zone, thus conserving the proliferative capacity of the resting zone chondrocytes. The data in the current study are consistent with this hypothesis; dexamethasone decreased proliferation in both the epiphyseal and the reserve resting zone.
In addition, dexamethasone-treated animals had more resting zone chondrocytes than did control animals, indicating that glucocorticoid slows the quantitative depletion of resting zone cells. This delayed depletion of stem-like cell in the resting zone could contribute to the slowing of senescence caused by glucocorticoid excess. This increased number of resting zone cells occurred despite decreased proliferation, suggesting that dexamethasone may slow the transition from resting to proliferative chondrocytes, thus conserving the pool of stem-like cells. We did not determine whether cessation of glucocorticoid treatment causes this transition from resting to proliferative chondrocytes to accelerate, which could contribute to catch-up growth.
Estrogen accelerates growth plate senescence . To explain this effect, we hypothesized that estrogen might accelerate resting zone chondrocyte proliferation, thus depleting the proliferative capacity more rapidly, or that estrogen might accelerate the quantitative depletion of chondrocytes from the resting zone. However, estrogen did neither; it decreased proliferation rate and had no significant effect on cell numbers. Thus, the mechanism by which estrogen accelerates senescence remains unclear.
We measured levels of circulating IGF-1. Although the decrease in serum IGF-1 due to estrogen was not statistically significant, we cannot exclude the possibility that a decrease in IGF-I might have contributed to the decrease in proliferation index. Also, we examined the effect of estrogen on the growth plate in male rabbits. The effect of estrogen might have been different in females; a sexually dimorphic response to estrogen has been demonstrated in rat growth plate chondrocytes in vitro (Ekstein et al. 2005) .
Figure 7
Effect of estrogen on proliferation of chondrocytes in the overall resting zone (A), and in the epiphyseal region (B), and the reserve region (C) of the resting zone. 4-week-old rabbits were treated with estradiol cypionate (70 g/kg im weekly) or vehicle (cottonseed oil) for two weeks. BrdU was infused during the second week of the treatment. BrdU-labeling was assessed immunohistochemically in the distal femur (DF), proximal tibia (PT), and distal tibia (DT). P values are for estrogen vs vehicle, ANOVA.
We speculate that estrogen might increase the loss of proliferative capacity that occurs with each cell cycle, or that estrogen might cause loss of proliferative capacity by a cell-cycle-independent mechanism. For example, if senescence is caused by epigenetic changes such as loss of DNA methylation with each cell cycle , then estrogen might act by decreasing expression of maintenance methylases, causing greater loss of methylation with each cell replication. The effects of estrogen on the resting zone chondrocytes could be mediated by the estrogen receptor-or -, both of which are expressed by resting zone chondrocytes in humans, rabbits, and rats , Nilsson et al. 2003 . The combination of a decreased rate of growth (in most mammals) and an increased rate of senescence seems to be an effect specific to estrogen (De Luca & Baron 1999) . Other growthinhibiting conditions, such as glucocorticoid excess and hypothyroidism (Marino et al. 2005) , decelerate growth plate senescence. The mechanism responsible for this paradoxical effect of estrogen remains to be determined.
In our study, we focused on the effects of estrogen on the resting zone and on growth plate senescence. However, estrogen may also act elsewhere in the growth plate to hasten epiphyseal fusion by other mechanisms. For example, estrogen may act on hypertrophic chondrocytes to stimulate fusion (Kennedy et al. 1999 . In addition, signals other than estrogen may contribute to fusion, including fibroblast growth factors, (Sobue et al. 2005 , Ornitz 2001 ), parathyroid hormonerelated protein (Schipani et al. 1997) , and insulin receptor substrate-1 (Hoshi et al. 2004) .
Although it was not one of the original aims of the study, we also observed that the proliferation rate of reserve resting zone chondrocytes was greater than the proliferation rate of epiphyseal resting zone chondrocytes at all ages studied except for 0 weeks of age. This finding supports the idea that the reserve chondrocytes represent a transition zone between the epiphyseal chondrocytes, which proliferate very slowly, and the proliferative chondrocytes, which proliferate rapidly. This concept is intuitively appealing in that the reserve region lies physically between the epiphyseal region and the proliferative zone. In addition, the reserve region contains pairs of flattened cells that give the appearance of nascent proliferative columns. Finally, the concept is supported by functional studies; after surgical ablation, the reserve region can apparently be regenerated by epiphyseal chondrocytes, and the proliferative zone can apparently be generated by reserve chondrocytes .
In conclusion, our findings support the hypotheses that growth plate senescence is caused by qualitative and quantitative depletion of stem-like cells in the resting zone. Our findings further suggest that growth-inhibiting conditions, such as glucocorticoid excess, slow senescence by slowing resting zone proliferation and slowing the numerical depletion of stem-like cells, thereby conserving the proliferative capacity of the growth plate. Estrogen appears to accelerate growth plate senescence without accelerating resting zone chondrocyte proliferation or accelerating the numerical depletion of these cells, suggesting that it might accelerate senescence by a proliferation-independent mechanism or by increasing the loss of proliferative capacity per cell cycle.
